• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Managed Markets, bye TK


<







9/30 - the day of new beginnings in Managed Markets. TK was only the beginning. Since little manny gangoli has significant influence as to who stays a whipping boy it is plausible that the red head stepchild billy stays, tard or mead take over and maybe gangstar Hayes stays? Who knows crap shoot. RIP.
 
























Similar threads